ATE110707T1 - Milchsäureacylate, ihre salze, ihr herstellungsverfahren und sie enthaltende kompositionen. - Google Patents

Milchsäureacylate, ihre salze, ihr herstellungsverfahren und sie enthaltende kompositionen.

Info

Publication number
ATE110707T1
ATE110707T1 AT91400472T AT91400472T ATE110707T1 AT E110707 T1 ATE110707 T1 AT E110707T1 AT 91400472 T AT91400472 T AT 91400472T AT 91400472 T AT91400472 T AT 91400472T AT E110707 T1 ATE110707 T1 AT E110707T1
Authority
AT
Austria
Prior art keywords
salts
acylate
lactic
production process
compositions containing
Prior art date
Application number
AT91400472T
Other languages
English (en)
Inventor
Hugues Noel
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of ATE110707T1 publication Critical patent/ATE110707T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C07C69/68Lactic acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
AT91400472T 1990-02-22 1991-02-21 Milchsäureacylate, ihre salze, ihr herstellungsverfahren und sie enthaltende kompositionen. ATE110707T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9002176A FR2658509B1 (de) 1990-02-22 1990-02-22

Publications (1)

Publication Number Publication Date
ATE110707T1 true ATE110707T1 (de) 1994-09-15

Family

ID=9394013

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91400472T ATE110707T1 (de) 1990-02-22 1991-02-21 Milchsäureacylate, ihre salze, ihr herstellungsverfahren und sie enthaltende kompositionen.

Country Status (13)

Country Link
US (1) US5401773A (de)
EP (1) EP0443956B1 (de)
JP (1) JPH05155814A (de)
KR (1) KR910021363A (de)
AT (1) ATE110707T1 (de)
AU (1) AU649011B2 (de)
CA (1) CA2036846A1 (de)
DE (1) DE69103648T2 (de)
DK (1) DK0443956T3 (de)
ES (1) ES2059068T3 (de)
FR (1) FR2658509B1 (de)
TW (1) TW211001B (de)
ZA (1) ZA91616B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132776C1 (de) * 1991-10-02 1992-08-27 Goldwell Ag, 6100 Darmstadt, De
DE4215501C2 (de) * 1992-05-12 1998-10-22 Kao Corp Haut- und Haarpflegemittel
US6247995B1 (en) 1996-02-06 2001-06-19 Bruce Bryan Bioluminescent novelty items
US5876995A (en) 1996-02-06 1999-03-02 Bryan; Bruce Bioluminescent novelty items
US6416960B1 (en) 1996-08-08 2002-07-09 Prolume, Ltd. Detection and visualization of neoplastic tissues and other tissues
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US7034402B1 (en) 2000-06-28 2006-04-25 Intel Corporation Device with segmented ball limiting metallurgy
AU2002325614A1 (en) * 2001-08-16 2003-03-03 Pharmacon-Forschung Und Beratung Gmbh Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
ES2587018T3 (es) * 2006-11-10 2016-10-20 L'oreal Composición cosmética que comprende un derivado de ácido cítrico y/o una de sus sales
KR101250812B1 (ko) * 2011-03-18 2013-04-04 미원상사주식회사 언데세노일 디펩타이드 유도체 및 이를 함유하는 피부미백용 화장료 조성물
JP5766674B2 (ja) * 2012-09-27 2015-08-19 敏 新川 リンパ痩身に使用する痩身具と痩身用塗布剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2221277B2 (de) * 1972-04-29 1981-01-22 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur Herstellung von Fettsäure-Milchsäure-Kondensationsprodukten
US3933825A (en) * 1973-05-14 1976-01-20 Bristol-Myers Company Amine salts of acyl lactylic acids
DE2456631A1 (de) * 1974-11-29 1976-08-12 Boehringer Sohn Ingelheim Neue ester der undecensaeure mit hydroxycarbonsaeureestern und verfahren zu ihrer herstellung
JPH0625090B2 (ja) * 1987-02-12 1994-04-06 花王株式会社 毛髪化粧料

Also Published As

Publication number Publication date
AU7128791A (en) 1991-08-29
JPH05155814A (ja) 1993-06-22
DK0443956T3 (da) 1994-10-03
AU649011B2 (en) 1994-05-12
KR910021363A (ko) 1991-12-20
EP0443956A1 (de) 1991-08-28
ZA91616B (en) 1992-03-25
ES2059068T3 (es) 1994-11-01
EP0443956B1 (de) 1994-08-31
DE69103648D1 (de) 1994-10-06
FR2658509A1 (de) 1991-08-23
TW211001B (de) 1993-08-11
FR2658509B1 (de) 1992-06-12
DE69103648T2 (de) 1995-01-12
US5401773A (en) 1995-03-28
CA2036846A1 (fr) 1991-08-23

Similar Documents

Publication Publication Date Title
DE69108854T2 (de) Haarbehandlungsmittel.
ATE184274T1 (de) N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
DK0707580T3 (da) Magnesiumomeprazol
ATE26120T1 (de) Substituierte acyl-derivate von 1,2,3,4tetrahydro-6,7-dimethoxy-3-isoquinolincarbons|ure.
ATE110707T1 (de) Milchsäureacylate, ihre salze, ihr herstellungsverfahren und sie enthaltende kompositionen.
FI875202A (fi) Steroider med en spiranring i 17-staellning, foerfarande foer framstaellning av dessa och anvaendning av dessa.
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
EP0421561A3 (en) 24-d-homo-vitamin d-derivatives, a process for their production, pharmaceutical compositions containing them and their use as medicines
HUT59410A (en) Process for producing 1-methyl carbapenem derivatives and pharmaceutical compositions comprising same as active ingredient
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
IL107315A0 (en) 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them
FR2687154B1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
ZA934110B (en) Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them
EP0432841A3 (en) Spiro-indoline-oxazine compounds with photochromatic and photosensitizing characteristics and the process for their preparation
HUT57227A (en) 2'-dezamino-4'-desoxy-4'-amino-8-fluoro-anthracycline derivatives, process for producing them as well as pharmaceutical preparatives containing said compounds as active substance
WO1987004435A3 (en) Xanthine compounds
SE8903313L (sv) Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem
ZA792678B (en) A new drug containing a cyclopentylaldehyde derivative and composition containing same
EP0604667A4 (de) Tranexamsäurederivate und sie enthaltende dermatologische zubereitungen.
ES478073A1 (es) Un procedimiento de preparacion de benzamidas.
IL98445A0 (en) Substituted n-oximidic acid derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee